you are here: Home News Vivimed Labs

Vivimed Labs

Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
Vivimed Labs Consolidated September 2023 Net Sales at Rs 33.64 crore, down 23.93% Y-o-Y
Vivimed Labs Standalone June 2023 Net Sales at Rs 33.00 crore, down 30.33% Y-o-Y
Vivimed Labs Consolidated June 2023 Net Sales at Rs 35.35 crore, down 29.45% Y-o-Y
Vivimed Labs Consolidated March 2023 Net Sales at Rs 37.03 crore, down 39.43% Y-o-Y
Vivimed Labs Standalone March 2023 Net Sales at Rs 39.72 crore, down 25.23% Y-o-Y
Vivimed Labs Consolidated December 2022 Net Sales at Rs 55.74 crore, down 1.38% Y-o-Y
Vivimed Labs Standalone December 2022 Net Sales at Rs 50.56 crore, down 2.59% Y-o-Y
Vivimed Labs Consolidated September 2022 Net Sales at Rs 44.22 crore, down 18.67% Y-o-Y
Vivimed Labs Standalone March 2022 Net Sales at Rs 53.12 crore, up 53.19% Y-o-Y
Vivimed Labs Standalone March 2022 Net Sales at Rs 53.12 crore, up 53.19% Y-o-Y
Vivimed Labs Consolidated March 2022 Net Sales at Rs 61.13 crore, up 56.78% Y-o-Y
Vivimed Labs Standalone December 2021 Net Sales at Rs 51.90 crore, down 16.87% Y-o-Y
Vivimed Labs Consolidated December 2021 Net Sales at Rs 56.52 crore, down 79.66% Y-o-Y
Bulk Deals | Equity Intelligence India buys 1% stake in Cupid; Plutus Capital raises holding in Mohini Health
Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India
Vivimed Labs shares hit upper circuit on govt nod to manufacture, market Favipiravir tablet to treat COVID-19
Vivimed Labs shares surge 20% on approvals for 3 products
Vivimed Labs Standalone December 2020 Net Sales at Rs 62.44 crore, down 0.53% Y-o-Y
Vivimed Labs share price up nearly 5% on approval of products
Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y
Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Vivimed Labs

Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y

Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y

Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y

Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y

Vivimed Labs Consolidated September 2023 Net Sales at Rs 33.64 crore, down 23.93% Y-o-Y

Vivimed Labs Standalone June 2023 Net Sales at Rs 33.00 crore, down 30.33% Y-o-Y

Vivimed Labs Consolidated June 2023 Net Sales at Rs 35.35 crore, down 29.45% Y-o-Y

Vivimed Labs Consolidated March 2023 Net Sales at Rs 37.03 crore, down 39.43% Y-o-Y

Vivimed Labs Standalone March 2023 Net Sales at Rs 39.72 crore, down 25.23% Y-o-Y

Vivimed Labs Consolidated December 2022 Net Sales at Rs 55.74 crore, down 1.38% Y-o-Y

Vivimed Labs Standalone December 2022 Net Sales at Rs 50.56 crore, down 2.59% Y-o-Y

Vivimed Labs Consolidated September 2022 Net Sales at Rs 44.22 crore, down 18.67% Y-o-Y

Vivimed Labs Standalone March 2022 Net Sales at Rs 53.12 crore, up 53.19% Y-o-Y

Vivimed Labs Standalone March 2022 Net Sales at Rs 53.12 crore, up 53.19% Y-o-Y

Vivimed Labs Consolidated March 2022 Net Sales at Rs 61.13 crore, up 56.78% Y-o-Y

Vivimed Labs Standalone December 2021 Net Sales at Rs 51.90 crore, down 16.87% Y-o-Y

Vivimed Labs Consolidated December 2021 Net Sales at Rs 56.52 crore, down 79.66% Y-o-Y

Bulk Deals | Equity Intelligence India buys 1% stake in Cupid; Plutus Capital raises holding in Mohini Health

Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India

Vivimed Labs shares hit upper circuit on govt nod to manufacture, market Favipiravir tablet to treat COVID-19

Vivimed Labs shares surge 20% on approvals for 3 products

Vivimed Labs Standalone December 2020 Net Sales at Rs 62.44 crore, down 0.53% Y-o-Y

Vivimed Labs share price up nearly 5% on approval of products

Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y

Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y